Gmo Us is trading at 21.60 as of the 30th of January 2025; that is 0.23 percent decrease since the beginning of the trading day. The fund's open price was 21.65. Gmo Us has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
GMO seeks to achieve the funds investment objective by investing primarily in equities of U.S. companies that are included in the SP SmallCap 600 Index or whose market capitalization at the time of investment is less than that of the 1000 largest publicly held companies. More on Gmo Small Cap
Gmo Small Cap [GCAVX] is traded in USA and was established 30th of January 2025. Gmo Us is listed under GMO category by Fama And French industry classification. The fund is listed under Small Value category and is part of GMO family. This fund currently has accumulated 336.01 M in assets under management (AUM) with minimum initial investment of 300 M. Gmo Small Cap is currently producing year-to-date (YTD) return of 3.4% with the current yeild of 0.02%, while the total return for the last 3 years was 8.0%.
Check Gmo Us Probability Of Bankruptcy
Gmo Us financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Us security.